1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,187 | 0,212 | 18:48 | |
| 0,189 | 0,208 | 18:33 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.01. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | 4 | HKEx | ||
| BRII BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 10.01. | BRII-B (02137): SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO NOMINEE DESIGNATION AGREEMENT | 1 | HKEx | ||
| 10.01. | BRII-B (02137): CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG | 1 | HKEx | ||
| 07.01. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 02.01. | Brii Biosciences acquires BRII-179 assets from VBI Vaccines | 3 | Pharmaceutical Business Review | ||
| 31.12.24 | Brii Biosciences Limited: Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study | 67 | PR Newswire | Further secures Brii's rights in BRII-179 with full control of intellectual property, future manufacturing and supply
Several combination treatment studies containing... ► Artikel lesen | |
| 31.12.24 | BRII-B (02137): DISCLOSEABLE TRANSACTION IN RELATION TO NOMINEE DESIGNATION AGREEMENT | - | HKEx | ||
| 20.12.24 | BRII-B (02137): INSIDE INFORMATION IN RELATION TO SHARE BUY-BACK PROGRAMME | - | HKEx | ||
| 19.11.24 | BRII-B (02137): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE | 2 | HKEx | ||
| 25.10.24 | BRII-B (02137): CANCELLATION OF SHARE OPTIONS AND RESTRICTED SHARE UNITS AND GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS | 1 | HKEx | ||
| 19.09.24 | BRII-B (02137): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 19.09.24 | BRII-B (02137): NOTIFICATION LETTER AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS | - | HKEx | ||
| 19.09.24 | BRII-B (02137): 2024 INTERIM REPORT | - | HKEx | ||
| 17.09.24 | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 07.06.24 | Brii Biosciences Limited: Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL Congress 2024 | 429 | PR Newswire | New translational data demonstrate that BRII-179-induced immune responses are associated with high HBsAg reduction in a subset of participants with chronic HBV infection
BRII-179 as add-on therapy... ► Artikel lesen | |
| 14.05.24 | Brii Biosciences Limited: Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies | 125 | PR Newswire | DURHAM, N.C. and BEIJING, May 13, 2024 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio " or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient... ► Artikel lesen | |
| 22.03.24 | Brii Biosciences Limited: Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results | 414 | PR Newswire | Transitioning HBV cure programs into multiple late-stage combination studies with interim results throughout 2024 and 2025 informing Company's registrational strategyIntegrating R&D, manufacturing... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIOGEN | 135,00 | -0,30 % | Biogen: Alzheimer-Mittel auf der Zielgeraden | Biogen und der Partner Eisai sind in Europa fast am Ziel. Das Alzheimer-Medikament Lecanemab (Leqembi) hat grünes Licht von der europäischen Arzneimittelbehörde (EMA) erhalten, nun muss nur noch die... ► Artikel lesen | |
| ILLUMINA | 83,05 | -2,85 % | Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today | ||
| NANOREPRO | 1,335 | -1,84 % | EQS-DD: NanoRepro AG: Dr. Olaf Stiller, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
25.02.2025 / 09:45... ► Artikel lesen | |
| BRAIN BIOTECH | 2,600 | +1,56 % | EQS-News: BRAIN Biotech AG: 3M GJ 24/25 - Jahresauftakt mit zweistelligem Umsatzwachstum im Kernsegment BRAINBiocatalysts | EQS-News: BRAIN Biotech AG
/ Schlagwort(e): Quartals-/Zwischenmitteilung
BRAIN Biotech AG: 3M GJ 24/25 - Jahresauftakt mit zweistelligem Umsatzwachstum im Kernsegment BRAINBiocatalysts... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,340 | +1,80 % | Bayer, BioNxt Solutions, Evotec - Künstliche Intelligenz als Gamechanger in der Pharmaforschung | Neue Technologien und innovative Lösungen werden die Medizin der Zukunft komplett verändern. Um sich bestmöglich darauf vorzubereiten, müssen Hürden wie Bürokratie, Geldprobleme oder veraltete Strukturen... ► Artikel lesen | |
| INFLARX | 1,275 | -5,20 % | InflaRx N.V.: InflaRx to Showcase Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting | ||
| SIRONA BIOCHEM | 0,037 | -10,98 % | Sirona Biochem präsentiert TFC-1326 in wegweisendem Bericht von Stonegate Healthcare | 15. Januar 2025 - Vancouver, British Columbia / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB:
ZSB) (OTC: SRBCF) freut sich bekannt zu geben, dass sein innovativer Anti-Aging-Wirkstoff TFC-1326... ► Artikel lesen | |
| TREVENA | 0,153 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 17.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.02.2025ISIN NameCA00208E3077 ATI... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,856 | +9,18 % | Defence Therapeutics Inc.: Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million | Montreal, Quebec--(Newsfile Corp. - January 31, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing... ► Artikel lesen | |
| BURCON NUTRASCIENCE | 0,056 | -1,07 % | Burcon NutraScience Corporation: Burcon Announces Details of $9.43 Million Rights Offering | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development... ► Artikel lesen | |
| CYTODYN | 0,310 | 0,00 % | CytoDyn Inc.: CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab | VANCOUVER, Washington, Feb. 24, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential... ► Artikel lesen | |
| TME PHARMA | 0,071 | 0,00 % | TME Pharma N.V.: TME Pharma CEO Message | Regulatory News:
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancer by targeting the tumor... ► Artikel lesen | |
| IMMUNIC | 1,161 | +1,66 % | EQS-News: Immunic AG: Immunic to Participate in Scientific and Investor Conferences in March | Issuer: Immunic AG
/ Key word(s): Conference
Immunic to Participate in Scientific and Investor Conferences in March
03.03.2025 / 12:30 CET/CEST
The issuer is solely... ► Artikel lesen | |
| PHIO PHARMACEUTICALS | 1,385 | +0,36 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series | Marlborough, Massachusetts--(Newsfile Corp. - February 26, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA... ► Artikel lesen | |
| IOVANCE BIOTHERAPEUTICS | 3,901 | -4,46 % | Pre-market Movers: Interactive Strength, DocGo, DLocal, Iovance Biotherapeutics, Acadia Healthcare | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.00 A.M. ET).In the Green Interactive Strength Inc. (TRNR) is up over 30% at... ► Artikel lesen |
BRII BIOSCIENCES LTD gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,191 Euro und damit -15,49 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRII BIOSCIENCES LTD finden Sie auf Wallstreet Online.
